See more : Rusta AB (publ) (RUSTA.ST) Income Statement Analysis – Financial Results
Complete financial analysis of Salona Global Medical Device Corporation (LNDZF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Salona Global Medical Device Corporation, a leading company in the Medical – Devices industry within the Healthcare sector.
You may be interested
- Miwon Chemicals Co., Ltd. (134380.KS) Income Statement Analysis – Financial Results
- Pure Hydrogen Corporation Limited (PH2.AX) Income Statement Analysis – Financial Results
- Great Portland Estates Plc (GPEAF) Income Statement Analysis – Financial Results
- FlexiInternational Software Inc. (FLXI) Income Statement Analysis – Financial Results
- Yantai Tayho Advanced Materials Co., Ltd. (002254.SZ) Income Statement Analysis – Financial Results
Salona Global Medical Device Corporation (LNDZF)
About Salona Global Medical Device Corporation
Salona Global Medical Device Corporation, through its subsidiaries, engages in the production and sale of medical devices and products in the United States. The company's medical devices are used for pain management, cold and hot therapy, transcutaneous electronic nerve and neuromuscular electrical stimulation, pulsed electromagnetic field technology, and ultrasound therapy. It also offers wearable technology and products that are used to enhance physical stability. The company was formerly known as Brattle Street Investment Corp. and changed its name to Salona Global Medical Device Corporation in December 2020. Salona Global Medical Device Corporation was incorporated in 2013 and is headquartered in Del Mar, California.
| Metric | 2023 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 62.63M | 18.31M | -33.55K | 352.13K | 3.15M | 3.94M | 3.94M | 2.10M | 359.01K |
| Cost of Revenue | 40.09M | 12.35M | 12.35M | 372.46K | 61.85K | 6.77M | 825.30K | 945.80K | 21.37K |
| Gross Profit | 22.53M | 5.96M | -12.38M | -20.33K | 3.09M | -2.83M | 3.12M | 1.16M | 337.64K |
| Gross Profit Ratio | 35.98% | 32.56% | 36,914.62% | -5.77% | 98.03% | -71.87% | 79.08% | 55.02% | 94.05% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 24.16M | 5.73M | 990.28K | 1.71M | 3.83M | 4.97M | 5.09M | 3.84M | 1.49M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 11.57K | 3.07K | 296.62K | 540.74K | 0.00 |
| SG&A | 24.16M | 5.73M | 990.28K | 1.71M | 3.85M | 4.97M | 5.39M | 4.38M | 1.49M |
| Other Expenses | 3.90M | 233.82K | -1.64M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 28.05M | 5.96M | 990.28K | 1.71M | 3.85M | 4.97M | 5.39M | 4.38M | 1.49M |
| Cost & Expenses | 68.15M | 18.31M | 990.28K | 2.08M | 3.91M | 11.74M | 6.21M | 5.33M | 1.51M |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 2.64M | 388.07K | 388.07K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 2.48M | 841.77K | 841.77K | 54.52K | 256.04K | 276.73K | 83.19K | 1.27K | -460.62K |
| EBITDA | -8.40M | -3.24M | -1.02M | -1.63M | -504.53K | -7.41M | 4.22M | -3.28M | -1.38M |
| EBITDA Ratio | -13.41% | -17.71% | 3,051.93% | -464.06% | -16.03% | -188.01% | 106.97% | -156.23% | -385.19% |
| Operating Income | -5.52M | -4.84M | -1.02M | -1.69M | -760.57K | -7.68M | -8.67M | -3.17M | -922.25K |
| Operating Income Ratio | -8.82% | -26.42% | 3,051.93% | -479.55% | -24.17% | -195.04% | -219.77% | -150.58% | -256.89% |
| Total Other Income/Expenses | -10.02M | 365.11K | -1.64M | 337.97K | 0.00 | -241.61K | 33.09K | 0.00 | 0.00 |
| Income Before Tax | -15.55M | -4.47M | -2.67M | -1.77M | -760.57K | -7.92M | -8.64M | -3.17M | -922.25K |
| Income Before Tax Ratio | -24.82% | -24.43% | 7,951.30% | -502.04% | -24.17% | -201.17% | -218.93% | -150.58% | -256.89% |
| Income Tax Expense | 57.07K | -101.62K | -101.62K | 613.11K | 0.00 | 135.29K | 26.19K | -74.81K | 230.31K |
| Net Income | -15.60M | -4.37M | -2.67M | -2.34M | -760.57K | -8.06M | -8.66M | -3.09M | -922.25K |
| Net Income Ratio | -24.91% | -23.87% | 7,951.30% | -664.91% | -24.17% | -204.61% | -219.59% | -147.03% | -256.89% |
| EPS | -0.16 | -0.10 | -0.06 | -0.07 | -0.02 | -0.24 | -0.29 | -0.13 | -0.15 |
| EPS Diluted | -0.16 | -0.10 | -0.06 | -0.07 | -0.02 | -0.24 | -0.29 | -0.13 | -0.15 |
| Weighted Avg Shares Out | 73.47M | 43.63M | 43.63M | 33.79M | 33.79M | 33.79M | 29.66M | 24.57M | 6.12M |
| Weighted Avg Shares Out (Dil) | 73.47M | 43.63M | 43.63M | 33.79M | 33.79M | 33.79M | 29.66M | 24.57M | 6.12M |
Salona Global Finalizes Name Change to Evome Medical Technologies to Reflect Turn Around and New Innovation Focus; Restructures Board of Directors
NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (the “Company”) (TSXV:SGMD), is pleased to announce its corporate name change to Evome Medical Technologies Inc. on January 22, 2024, and trading of the Company's common shares...
Salona Global Announces Exclusive Partnership with Recently Launched U.S. Military Veteran (VA) Focused Distribution Company
NEW YORK, Jan. 11, 2024 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (the “Company”) (TSXV:SGMD), announced today it has executed an exclusive distribution agreement with Veteran Medical Solutions, LLC (“VMS”), a U.S. military veteran owned company that is positioned...
Salona Global Announces the Debut of the Biodex Reactive Step Trainer, a Revolutionary Balance Training System to Reduce Falls; Commences AI Enabled Software Component
NEW YORK, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (the “Company”) (TSXV:SGMD), announced today the debut of the Biodex Reactive Step Trainer (“RST”): A revolutionary medical device that combines Biodex Rehab's industry leading gait trainer platform...
Salona Global Announces the Debut of the Biodex SpaceTek Knee™, a Revolutionary Portable Isokinetic Knee Dynamometer Medical Device Developed in NASA Collaboration
NEW YORK, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (the “Company”) (TSXV:SGMD), soon to be renamed Evome Medical Technologies Inc., today announced the debut of the Biodex SpaceTek Knee™ Device: A revolutionary, portable medical device for...
Salona Global Completes Turn Around Plan with Profitable Third Quarter, Posting Record Results with 18.5% Quarterly Organic Revenue Growth and 29% Quarterly Gross Profit Growth; Generates $749,425 in Adjusted EBITDA for the Quarter
NEW YORK, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (the “Company”) (TSXV:SGMD), soon to be renamed Evome Medical Technologies Inc., today announced financial highlights for its third quarter, ending September 30, 2023.
Salona Global Announces Large International Order from Polish Distributor Expected to be Delivered in the Current Quarter; Increases Year-over-Year Revenues 157% For the Polish Market
NEW YORK, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (the “Company”) (TSXV:SGMD) today announced it has booked a $837,000 order for its Biodex System Pro4™ and Biodex System 4 MVP™ Isokinetic dynamometer machines from its international...
Salona Global Announces Plans to Change Name to Evome Medical Technologies Inc.; Confirms Positive Adjusted EBITDA and Net Profit for Q3 2023; Appoints New CFO
NEW YORK, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (the “Company”) (TSXV:SGMD) today announced its intention to change its name to “Evome Medical Technologies Inc.” subject to governmental and regulatory approvals. The proposed name change reflects...
Salona Global Announces Expansion of Bank Line
NEW YORK, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (“Salona Global”, “SGMD” or the “Company”) (TSXV:SGMD) today announced the expansion of its bank line. On September 12, 2023, an operating subsidiary of the Company, Biodex Medical...
Salona Global Posts Second Quarter Results and Provides Update on Turn Around Plan
NEW YORK, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (“Salona Global” or the “Company”) (TSXV:SGMD) today posted financial results for the second quarter of 2023, ending June 30, 2023, and provided an update on its turn-around...
Source: https://incomestatements.info
Category: Stock Reports